Tools for organizing life sciences data are provided by PubGene.

About PubGene

PubGene is a company based in Oslo (Norway).. PubGene offers products and services including Coremine Oncology, Coremine Medical, and Vitae Evidence. PubGene operates in a competitive market with competitors including Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.

  • Headquarter Oslo, Norway
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pubgene As
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $55.01 K (USD), Grant

    Oct 31, 2015

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PubGene

PubGene offers a comprehensive portfolio of products and services, including Coremine Oncology, Coremine Medical, and Vitae Evidence. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tool for mining evidence in oncology treatments.

Platform for general medical data analysis and insights.

Service for developing evidence-based personalized medicine solutions.

Funding Insights of PubGene

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $55,006
  • First Round

    (01 May 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2015 Amount Grant - PubGene Valuation

investors

May, 2015 Amount Grant - PubGene Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PubGene

PubGene has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PubGene

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PubGene

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pubgene Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PubGene

PubGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-based data-mining tools for scientific evidence discovery are provided.
domain founded_year HQ Location
Provider of AI solutions transforming medical text into enriched healthcare data
domain founded_year HQ Location
Biological and chemical data are managed securely in a database.
domain founded_year HQ Location
AI based drug purposing platform to identify treatments for rare diseases
domain founded_year HQ Location
Research communication services are provided to boost visibility and impact.
domain founded_year HQ Location
Medical news and research are personalized for physicians.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pubgene

Frequently Asked Questions about PubGene

Where is PubGene located?

PubGene is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.

What does PubGene do?

Pubgene provides tools for life sciences. It provides drug development, disease prevention, diagnostics and other solutions pertaining to human health and wellbeing. It develops bioinformatics solutions for microarray approaches, including gene and protein arrays and provides a software-as-a-service platform, Coremine, which enables domain-specific community portals combining context networks. Coremine is a family of products PubGene has developed using the companys patented text mining algorithms, as well as big biomedical data integration and analysis pipeline and consists of Coremine Oncology which enables the analysis of complex cancer-specific mutational, Coremine Medical, the first domain-specific information community built on top of the COREMINE Platform, and the Coremine Platform which claims to enable users to mine large repositories of information using advanced statistical text mining algorithms and specialized Natural Language Processing (NLP).

Who are the top competitors of PubGene?

PubGene's top competitors include Causaly, ScienceIO and BioSymetrics.

What products or services does PubGene offer?

PubGene offers Coremine Oncology, Coremine Medical, and Vitae Evidence.

Who are PubGene's investors?

PubGene has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available